HomeCompareWEIMX vs JNJ

WEIMX vs JNJ: Dividend Comparison 2026

WEIMX yields 22.06% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 WEIMX wins by $62.8K in total portfolio value
10 years
WEIMX
WEIMX
● Live price
22.06%
Share price
$15.55
Annual div
$3.43
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$82.8K
Annual income
$8,351.62
Full WEIMX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — WEIMX vs JNJ

📍 WEIMX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodWEIMXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, WEIMX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
WEIMX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

WEIMX
Annual income on $10K today (after 15% tax)
$1,875.47/yr
After 10yr DRIP, annual income (after tax)
$7,098.88/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, WEIMX beats the other by $6,395.26/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of WEIMX + JNJ for your $10,000?

WEIMX: 50%JNJ: 50%
100% JNJ50/50100% WEIMX
Portfolio after 10yr
$51.4K
Annual income
$4,589.70/yr
Blended yield
8.93%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

WEIMX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

WEIMX buys
0
JNJ buys
0
No recent congressional trades found for WEIMX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricWEIMXJNJ
Forward yield22.06%3.36%
Annual dividend / share$3.43$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$82.8K$20.0K
Annual income after 10y$8,351.62$827.78
Total dividends collected$49.5K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: WEIMX vs JNJ ($10,000, DRIP)

YearWEIMX PortfolioWEIMX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$12,906$2,206.43$10,676$355.77+$2.2KWEIMX
2$16,471$2,661.42$11,407$389.39+$5.1KWEIMX
3$20,799$3,174.32$12,198$426.53+$8.6KWEIMX
4$26,001$3,746.05$13,056$467.62+$12.9KWEIMX
5$32,197$4,376.61$13,987$513.12+$18.2KWEIMX
6$39,516$5,065.12$14,998$563.56+$24.5KWEIMX
7$48,092$5,809.81$16,098$619.52+$32.0KWEIMX
8$58,067$6,608.11$17,295$681.69+$40.8KWEIMX
9$69,588$7,456.70$18,599$750.82+$51.0KWEIMX
10$82,811$8,351.62$20,022$827.78+$62.8KWEIMX

WEIMX vs JNJ: Complete Analysis 2026

WEIMXStock

The fund primarily invests in common stocks of smaller companies that have a market capitalization of $500 million or less at the time of the fund's initial investment. It focuses on micro-cap companies which appear to be underpriced relative to their "private market value." Private market value is the value which the sub-adviser believes informed investors would be willing to pay to acquire a company. The fund may also invest up to 25% of its total assets in foreign securities and in European Depositary Receipts ("EDRs") or American Depositary Receipts ("ADRs").

Full WEIMX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this WEIMX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

WEIMX vs SCHDWEIMX vs JEPIWEIMX vs OWEIMX vs KOWEIMX vs MAINWEIMX vs ABBVWEIMX vs MRKWEIMX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.